What AI says about Biodesix

Biodesix is a leading diagnostic solutions company focused on personalized diagnostics to improve patient care, with a focus on lung disease and early detection. It provides advanced diagnostic tests and custom development services to support biopharma, life sciences, and research institutions in developing diagnostics, tools, and therapeutics (for example Nodify Lung Nodule Risk Assessment and IQLung Cancer Treatment Guidance). The tests have NYS CLEP approval but have not yet been cleared or approved by the FDA.

AI named Biodesix in August 2026.